Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LACOSAMIDE IN NEONATES WITH REPEATED ELECTROENCEPHALOGRAPHIC NEONATAL SEIZURES

LENS

Condition: Neurology
Phase: II/III
Clinicaltrials.gov ID: NCT04519645

What is the goal of the study?

SP0968 is a Phase 2/3, multicenter, open-label, randomized, active comparator study to evaluate the efficacy, safety, and PK of LCM in neonates with repeated ENS compared with an Active Comparator chosen based on StOC per the local practice and treatment guidelines.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Niranjana Natarajan
Study Team Member: Mikaela Gatterman, Mikaela.Gatterman@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.